Elevation of plasma phosphorylated tau181 during neurological illnesses affecting consciousness and kidney dysfunction

INTRODUCTION: Phosphorylated tau (p‐tau)181 has become a promising blood‐based Alzheimer's disease (AD) biomarker. We studied the agreement of plasma p‐tau181 and cerebrospinal fluid (CSF) markers in patients with alteration of consciousness (AOC). METHODS: Plasma and CSF were simultaneously co...

Descripción completa

Detalles Bibliográficos
Autores principales: Thanapornsangsuth, Poosanu, Ongphichetmetha, Tatchaporn, Luechaipanit, Watayuth, Hemachudha, Pasin, Hemachudha, Thiravat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Fluid Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523798/
https://www.ncbi.nlm.nih.gov/pubmed/36204656
http://dx.doi.org/10.1002/dad2.12358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523798/
https://www.ncbi.nlm.nih.gov/pubmed/36204656
http://dx.doi.org/10.1002/dad2.12358

Ejemplares similares